ZhuZhou QianJin Pharmaceutical Co.,Ltd
Symbool: 600479.SS
SHH
10.91
CNYMarktprijs vandaag
17.9517
Koers/Winst Verhouding
0.4616
Koers/Winst Groei Verhouding
4.56B
MRK Kapitalisatie
- 0.03%
DIV Rendement
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479-SS) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1997.9 | 1731.7 | 1369.7 | |||||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | -45.7 | 491.7 | 736.8 | |||||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 967 | 983.9 | 921.6 | |||||||||||||||||||||||
balance-sheet.row.inventory | 0 | 534.1 | 599 | 547.8 | |||||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 15.4 | 198.9 | 78.1 | |||||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 3514.5 | 3513.5 | 2917.3 | |||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 589.9 | 622.8 | 630.2 | |||||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 14.1 | 14.1 | 14.1 | |||||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 238.3 | 221.8 | 219.6 | |||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 252.3 | 235.9 | 233.7 | |||||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 293.3 | -304.1 | -546.1 | |||||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 22.7 | 6.6 | 4.1 | |||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 4.2 | 547.3 | 821 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 1162.4 | 1108.5 | 1143 | |||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 4676.9 | 4622 | 4060.2 | |||||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 647.5 | 780.9 | 511.7 | |||||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 78.2 | 79.5 | 88.6 | |||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 70.6 | 72.5 | 35.6 | |||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 38.5 | 44.8 | 60.3 | |||||||||||||||||||||||
Deferred Revenue Non Current | 0 | 38 | 44.4 | 51.3 | |||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 69.1 | 705.6 | 75.5 | |||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 108.3 | 108.5 | 131.9 | |||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 31.5 | 32.8 | 44.8 | |||||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 1650.1 | 1805.7 | 1360.3 | |||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 428.9 | 429.8 | 418.5 | |||||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 1142.5 | 970.8 | 930.7 | |||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 280.8 | 275.3 | 298.1 | |||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 537.5 | 540.3 | 503 | |||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 2389.7 | 2216.2 | 2150.4 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 4676.9 | 4622 | 4060.2 | |||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 637.1 | 600.1 | 549.5 | |||||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 3026.8 | 2816.3 | 2699.9 | |||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||||||||||||
Total Investments | 0 | 247.6 | 187.6 | 190.8 | |||||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 116.7 | 124.2 | 148.9 | |||||||||||||||||||||||
balance-sheet.row.net-debt | 0 | -1881.2 | -1115.7 | -484 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 395 | 388.3 | 374.7 | ||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 103.7 | 95.6 | 85.9 | ||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -2.8 | -3.6 | 2.7 | ||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 2.8 | 3.6 | -2.7 | ||||||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -81.7 | 246.9 | 65.8 | ||||||||||||||||||||||
cash-flows.row.account-receivables | 0 | -8.7 | -163.7 | 275.9 | ||||||||||||||||||||||
cash-flows.row.inventory | 0 | 62.3 | -51.2 | -52.4 | ||||||||||||||||||||||
cash-flows.row.account-payables | 0 | -132.5 | 465.4 | -160.4 | ||||||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -2.8 | -3.6 | 2.7 | ||||||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 26.1 | 2.7 | -40.9 | ||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -44 | -34.4 | -71.9 | ||||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0.2 | 30.8 | ||||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -402 | -2102 | -1570 | ||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 1031.2 | 2258.4 | 1567.7 | ||||||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0.1 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 585.3 | 122.1 | -43.3 | ||||||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -50.7 | -15 | -127.6 | ||||||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -147.9 | -248.6 | -429.5 | ||||||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -13.1 | -0.5 | 36.5 | ||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -202 | -264.2 | -520.6 | ||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 826.4 | 591.4 | -78.3 | ||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1928.3 | 1101.9 | 510.5 | ||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1101.9 | 510.5 | 588.8 | ||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 443.1 | 733.5 | 485.6 | ||||||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -44 | -34.4 | -71.9 | ||||||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 399.1 | 699 | 413.7 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 3798.5 | 4026.3 | 3663.8 | |||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 2046.7 | 2289.9 | 2032.2 | |||||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 1751.8 | 1736.4 | 1631.6 | |||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | -3337.9 | 218.6 | 189.1 | |||||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 3337.9 | 1311.7 | 1261.1 | |||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 3337.9 | 3601.5 | 3293.4 | |||||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 51.4 | 9.8 | 11.9 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 1.7 | 2.2 | 2.1 | |||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1.5 | 1.6 | -2.8 | |||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | -3337.9 | 218.6 | 189.1 | |||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -1.5 | 1.6 | -2.8 | |||||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 1.7 | 2.2 | 2.1 | |||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 103.7 | 104.2 | 47.3 | |||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 460.6 | 444.2 | 436.2 | |||||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 459.1 | 445.8 | 433.4 | |||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 65.4 | 57.6 | 58.7 | |||||||||||||||||||||||
income-statement-row.row.net-income | 0 | 320.4 | 302.5 | 302.1 |
Vaak gestelde vragen
Wat is ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) totale activa?
ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) totale activa is 4676882466.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.465.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.073.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.121.
Wat is ZhuZhou QianJin Pharmaceutical Co.,Ltd (600479.SS) nettowinst (netto-inkomen)?
De nettowinst is 320405834.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 116705915.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 3337921320.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.